Fiera Capital Corp lifted its stake in Dolby Laboratories (NYSE:DLB – Free Report) by 31.8% in the 4th quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 812,021 shares of the electronics maker’s stock after purchasing an additional 195,795 shares during the quarter. Fiera Capital Corp’s holdings in Dolby Laboratories were worth $52,148,000 as of its most recent SEC filing.
Several other hedge funds and other institutional investors have also recently modified their holdings of the stock. Parallel Advisors LLC raised its position in shares of Dolby Laboratories by 70.0% in the 4th quarter. Parallel Advisors LLC now owns 10,447 shares of the electronics maker’s stock valued at $671,000 after purchasing an additional 4,302 shares during the last quarter. TD Asset Management Inc raised its position in shares of Dolby Laboratories by 13.9% in the 4th quarter. TD Asset Management Inc now owns 32,800 shares of the electronics maker’s stock valued at $2,106,000 after purchasing an additional 4,000 shares during the last quarter. Goldman Sachs Group Inc. raised its position in shares of Dolby Laboratories by 7.4% in the 4th quarter. Goldman Sachs Group Inc. now owns 1,010,129 shares of the electronics maker’s stock valued at $64,870,000 after purchasing an additional 69,821 shares during the last quarter. AXQ Capital LP purchased a new position in shares of Dolby Laboratories in the 4th quarter valued at approximately $731,000. Finally, Norges Bank purchased a new position in shares of Dolby Laboratories in the 4th quarter valued at approximately $54,966,000. 58.56% of the stock is owned by hedge funds and other institutional investors.
Dolby Laboratories Trading Up 0.4%
DLB opened at $53.97 on Tuesday. Dolby Laboratories has a 12-month low of $52.45 and a 12-month high of $77.00. The firm has a market capitalization of $5.11 billion, a PE ratio of 21.33 and a beta of 0.81. The firm has a 50 day moving average of $58.87 and a two-hundred day moving average of $62.54.
Dolby Laboratories Announces Dividend
The firm also recently declared a quarterly dividend, which was paid on Wednesday, May 20th. Shareholders of record on Tuesday, May 12th were given a dividend of $0.36 per share. The ex-dividend date of this dividend was Tuesday, May 12th. This represents a $1.44 dividend on an annualized basis and a yield of 2.7%. Dolby Laboratories’s dividend payout ratio (DPR) is currently 56.92%.
Wall Street Analyst Weigh In
Several equities analysts recently commented on the stock. Wall Street Zen raised shares of Dolby Laboratories from a “hold” rating to a “buy” rating in a research report on Saturday, May 30th. Barrington Research reaffirmed an “outperform” rating and issued a $90.00 price objective on shares of Dolby Laboratories in a research report on Monday, April 27th. Finally, Weiss Ratings reaffirmed a “hold (c-)” rating on shares of Dolby Laboratories in a research report on Friday, March 27th. Three research analysts have rated the stock with a Buy rating and two have issued a Hold rating to the company. Based on data from MarketBeat, the stock presently has an average rating of “Moderate Buy” and a consensus target price of $90.75.
Check Out Our Latest Stock Report on Dolby Laboratories
Insider Buying and Selling at Dolby Laboratories
In other news, CMO Todd Pendleton sold 11,876 shares of Dolby Laboratories stock in a transaction that occurred on Friday, May 22nd. The shares were sold at an average price of $54.55, for a total transaction of $647,835.80. Following the completion of the transaction, the chief marketing officer directly owned 41,480 shares of the company’s stock, valued at $2,262,734. The trade was a 22.26% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Also, SVP John D. Couling sold 7,666 shares of Dolby Laboratories stock in a transaction that occurred on Monday, June 1st. The shares were sold at an average price of $55.62, for a total transaction of $426,382.92. Following the transaction, the senior vice president directly owned 118,727 shares of the company’s stock, valued at approximately $6,603,595.74. This trade represents a 6.07% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Over the last quarter, insiders sold 39,791 shares of company stock valued at $2,231,653. 37.93% of the stock is owned by corporate insiders.
About Dolby Laboratories
Dolby Laboratories, Inc is a global leader in audio and imaging technologies, specializing in the development, licensing and deployment of solutions that enhance entertainment and communications experiences. The company’s core business revolves around creating advanced audio codecs, noise reduction systems and spatial sound technologies for a wide range of applications, including cinema, broadcast, gaming, streaming and personal devices. Dolby’s licensing model enables consumer electronics manufacturers, content creators and service providers to integrate its technologies into products such as televisions, smartphones, home theater systems and set-top boxes.
Among its flagship innovations are Dolby Atmos, an immersive audio format that delivers three-dimensional soundscapes for theaters and home systems; Dolby Digital and Dolby Digital Plus, widely adopted audio compression formats for broadcast and streaming; and Dolby Vision, a high-dynamic-range imaging technology that expands color, contrast and brightness in displays.
Read More
- Five stocks we like better than Dolby Laboratories
- 3 Stocks With Fresh Catalysts to Watch Before the July 4
- Amprius Insiders Are Selling: Should Investors Be Worried?
- A Weaker Dollar Could Put These 3 Industrial Stocks Back in Focus
- A Market Rotation Toward Quality Will Benefit These 3 ETFs
Want to see what other hedge funds are holding DLB? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Dolby Laboratories (NYSE:DLB – Free Report).
Receive News & Ratings for Dolby Laboratories Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Dolby Laboratories and related companies with MarketBeat.com's FREE daily email newsletter.
